PAIGE MCDONALD: Open Payments
NPI 1528004264 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 53 payments from 14 companies in 2025. Trend: 2023 $614 · 2024 $1,400 · 2025 $1,008
Food & beverage: $1,008
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 19 | $190 |
| ABBVIE INC. | 7 | $142 |
| GENZYME CORPORATION | 1 | $123 |
| Novartis Pharmaceuticals Corporation | 5 | $108 |
| Amgen Inc. | 4 | $76 |
| LEO Pharma Inc. | 3 | $74 |
| Incyte Corporation | 2 | $51 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $46 |
| Organon LLC | 3 | $45 |
Products named: NEMLUVIO, DUPIXENT, OTEZLA, COSENTYX, DALVANCE, ADBRY, Opzelura, Winlevi.
Industry payments across AL — which companies pay providers there.
